Spanish functional-foods concern Puleva Biotech reported a EUR2.2m (US$2.73m) pretax profit in the first quarter of 2006, up 314% from EUR523,000 reported for the first quarter of 1005. These gains were largely driven by a EUR1.6m stock-sale gain, the company said in a statement issued with Stock Market watchdog Comision Nacional de Valores (CNMV) on Monday (24 April).